FTSE 100

FTSE 100 Market news covers the latest developments for the FTSE 100 Index, which tracks the 100 most highly capitalised blue‑chip companies listed on the London Stock Exchange.

This category includes updates on company admissions and delistings, quarterly and annual results, mergers and acquisitions, board appointments and departures, regulatory news and policy changes.

GSK to acquire IDRx, boosting gastrointestinal cancer portfolio

GSK to acquire IDRx for up to $1.15B, bolstering its GI cancer portfolio with IDRX-42, a promising therapy targeting all key KIT mutations in GIST...

Entain Plc reiterates FY24 EBITDA guidance

Entain plc reaffirms its FY24 outlook despite mixed sports betting results. BetMGM maintains a cautious EBITDA forecast amid an investment-heavy year...

J Sainsbury Plc boosts market share and sales with record-breaking Christmas

J Sainsbury Plc achieved its fifth consecutive year of Christmas market share growth, with strong sales and customer satisfaction during the festive season...

FDA accepts review of GSK Plc’s prefilled Shingrix syringe for vaccine approval

GSK's Shingrix aims for FDA-approved prefilled syringe to simplify shingles vaccination, enhancing convenience for healthcare providers...

Marks and Spencer Group Plc achieves record sales in Q3

Marks and Spencer Group Plc reports strong festive trading for Q3 2024, with notable sales growth in Food, Clothing, Home & Beauty despite challenges...

Unite Group Plc reports strong student accommodation demand for 2025/26

Unite Group plc updates on strong trading and valuation growth, with 66% of beds sold for 2025/26. Expect full occupancy and 4-5% rental growth...

Tesco Plc reports record Christmas sales and market share growth

Tesco Plc (LON:TSCO) reports a strong Q3 and Christmas trading performance for 2024/25, marking significant sales growth and increased market share...

Halma Plc CFO Steve Gunning to retire, Carole Cran appointed as CFO Designate

Halma plc announces CFO transition with Steve Gunning retiring in 2025 and Carole Cran stepping in, continuing the company's growth strategy...

NEXT plc reports strong Christmas sales, raises profit guidance for 2025

NEXT plc (LON:NXT) boosts profit forecasts as holiday sales surpass expectations, reporting a 10% rise in pre-tax profit and strong future growth guidance...

GSK Plc’s ADC receives US FDA Breakthrough Therapy Designation

GSK's ADC GSK5764227 gains FDA Breakthrough Therapy status for treating relapsed or refractory osteosarcoma, addressing critical unmet medical needs...

easyJet Plc Non-Executive Director Moni Mannings OBE to step down

easyJet plc announces leadership updates as Moni Mannings steps down. Julie Chakraverty joins the Board, enhancing tech and financial expertise...

Kingfisher Plc appoints Ian McLeod as a Non-Executive Director

Kingfisher plc announces the appointment of Ian McLeod as Non-Executive Director, while Catherine Bradley steps down after four years of dedicated service...

GSK Plc’s Nucala approved in China as a treatment for CRSwNP

GSK's Nucala has been approved in China as an add-on treatment for CRSwNP, marking the first anti-IL-5 therapy for adults with this chronic condition...

Rio Tinto Plc 2025 dividend schedule and key event dates

Discover Rio Tinto plc's (LON:RIO) key financial and corporate event dates for 2025, including dividend announcements and annual general meetings...

Tim Cobbold named Chair of Spirax Group, succeeding Jamie Pike

Tim Cobbold becomes Chair of Spirax Group, succeeding Jamie Pike. Cobbold will lead Board initiatives and engage with shareholders to drive growth...

Vodafone Group Plc completes sale of its Italian operations to Swisscom

Vodafone Group Plc completes the sale of Vodafone Italy to Swisscom AG for €8 billion, aiding debt reduction and shareholder returns...

Aviva acquires Direct Line in £3.7 billion cash and share deal

Aviva plc announces a strategic acquisition of Direct Line, enhancing its growth and performance. The deal offers benefits for both customers and shareholders...

AstraZeneca’s Tagrisso approved in the EU for patients with unresectable NSCLC

AstraZeneca's Tagrisso gains EU approval for treating advanced NSCLC, showing significant efficacy in reducing disease progression in key trials...

GSK Plc FIRST trial meetss primary endpoint in ovarian cancer

GSK reports success in phase III trial of Zejula and Jemperli for advanced ovarian cancer, achieving significant progression-free survival improvement...
Search

Funds

Interviews

GSK to acquire IDRx, boosting gastrointestinal cancer portfolio

GSK to acquire IDRx for up to $1.15B, bolstering its GI cancer portfolio with IDRX-42, a promising therapy targeting all key KIT mutations in GIST...

Entain Plc reiterates FY24 EBITDA guidance

Entain plc reaffirms its FY24 outlook despite mixed sports betting results. BetMGM maintains a cautious EBITDA forecast amid an investment-heavy year...

J Sainsbury Plc boosts market share and sales with record-breaking Christmas

J Sainsbury Plc achieved its fifth consecutive year of Christmas market share growth, with strong sales and customer satisfaction during the festive season...

FDA accepts review of GSK Plc’s prefilled Shingrix syringe for vaccine approval

GSK's Shingrix aims for FDA-approved prefilled syringe to simplify shingles vaccination, enhancing convenience for healthcare providers...

Marks and Spencer Group Plc achieves record sales in Q3

Marks and Spencer Group Plc reports strong festive trading for Q3 2024, with notable sales growth in Food, Clothing, Home & Beauty despite challenges...

Unite Group Plc reports strong student accommodation demand for 2025/26

Unite Group plc updates on strong trading and valuation growth, with 66% of beds sold for 2025/26. Expect full occupancy and 4-5% rental growth...

Tesco Plc reports record Christmas sales and market share growth

Tesco Plc (LON:TSCO) reports a strong Q3 and Christmas trading performance for 2024/25, marking significant sales growth and increased market share...

Halma Plc CFO Steve Gunning to retire, Carole Cran appointed as CFO Designate

Halma plc announces CFO transition with Steve Gunning retiring in 2025 and Carole Cran stepping in, continuing the company's growth strategy...

NEXT plc reports strong Christmas sales, raises profit guidance for 2025

NEXT plc (LON:NXT) boosts profit forecasts as holiday sales surpass expectations, reporting a 10% rise in pre-tax profit and strong future growth guidance...

GSK Plc’s ADC receives US FDA Breakthrough Therapy Designation

GSK's ADC GSK5764227 gains FDA Breakthrough Therapy status for treating relapsed or refractory osteosarcoma, addressing critical unmet medical needs...

easyJet Plc Non-Executive Director Moni Mannings OBE to step down

easyJet plc announces leadership updates as Moni Mannings steps down. Julie Chakraverty joins the Board, enhancing tech and financial expertise...

Kingfisher Plc appoints Ian McLeod as a Non-Executive Director

Kingfisher plc announces the appointment of Ian McLeod as Non-Executive Director, while Catherine Bradley steps down after four years of dedicated service...

GSK Plc’s Nucala approved in China as a treatment for CRSwNP

GSK's Nucala has been approved in China as an add-on treatment for CRSwNP, marking the first anti-IL-5 therapy for adults with this chronic condition...

Rio Tinto Plc 2025 dividend schedule and key event dates

Discover Rio Tinto plc's (LON:RIO) key financial and corporate event dates for 2025, including dividend announcements and annual general meetings...

Tim Cobbold named Chair of Spirax Group, succeeding Jamie Pike

Tim Cobbold becomes Chair of Spirax Group, succeeding Jamie Pike. Cobbold will lead Board initiatives and engage with shareholders to drive growth...

Vodafone Group Plc completes sale of its Italian operations to Swisscom

Vodafone Group Plc completes the sale of Vodafone Italy to Swisscom AG for €8 billion, aiding debt reduction and shareholder returns...

Aviva acquires Direct Line in £3.7 billion cash and share deal

Aviva plc announces a strategic acquisition of Direct Line, enhancing its growth and performance. The deal offers benefits for both customers and shareholders...

AstraZeneca’s Tagrisso approved in the EU for patients with unresectable NSCLC

AstraZeneca's Tagrisso gains EU approval for treating advanced NSCLC, showing significant efficacy in reducing disease progression in key trials...

GSK Plc FIRST trial meetss primary endpoint in ovarian cancer

GSK reports success in phase III trial of Zejula and Jemperli for advanced ovarian cancer, achieving significant progression-free survival improvement...
Search

Funds

FTSE 100

FTSE 100

Funds